At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Nov 12, 2026 at 10:58 ET
Two senior executives at Bio-Rad (President & COO and EVP/President of Life Science Group) sold a combined $899K in open-market shares on November 9, 2026, eight days after the company reported a Q3 earnings beat with revenue slightly above consensus but maintained guidance for a potential full-year revenue decline. The sales are not under 10b5-1 plans and follow the earnings release, suggesting possible profit-taking or portfolio rebalancing after the positive results.
- President & COO Jonathan DiVincenzo sold 919 shares at $390.47 for $359K on Nov 9, 2026
- EVP/President LSG James Barry sold 1,400 shares at $385.63 for $540K on Nov 9, 2026
- Total open-market sales of $899K represent ~0.009% of Bio-Rad's $10.4B market cap
- Neither sale was executed under a 10b5-1 plan
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access